Search

everythinglearnresearchcommunity

for

Search:↓

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

The project developed and tested a method using plasma rich platelets to treat hair loss.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

Drug repurposing offers a faster, cheaper way to find treatments for rare diseases.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

The FDA approved a new Pfizer drug for hair loss in teens.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Paroxetine relieves pain by increasing allopregnanolone levels.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Apremilast may help treat hair loss in alopecia areata.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Careful diagnosis is crucial in premature pubarche cases, as 20% have other conditions.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Combining α1A-blockers with Prozac is more effective for treating premature ejaculation than Prozac alone.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

The FDA did not approve a testosterone drug because of safety concerns.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The new controlled release PRP therapy shows promise for hair growth in women.

PRP shows promise in healing but needs a standardized, safe preparation method.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.